INS and liver disorder: Previous clinical trials where hepatic effects of insulin therapy in diabetic patients were explored, focused on hepatic fat content and non-specific circulating markers of the disease (e.g., aminotransferases) with no evaluation of liver histology and hence on progressive liver disease [12–19].